New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
August 16, 2018 - Sun Pharma announced the FDA approval of CEQUA (cyclosporine [CsA]), to increase tear production in patients with keratoconjunctivitis sicca (dry eye).
Download PDF
Return to publications
